ABBV
64
-4
VMC
60
4
KEY
36
9
PNR
39
-2
CNX
46
-2
LMT
45
-4
RL
59
4
TDC
28
2
JCI
42
4
O
39
2
ORCL
52
5
MSFT
48
2
JPM
55
2
CI
63
-5
AES
44
-3
MLM
48
3
ALL
54
-4
APD
37
-3
PHM
43
-5
URBN
52
-3
ABBV
64
-4
VMC
60
4
KEY
36
9
PNR
39
-2
CNX
46
-2
LMT
45
-4
RL
59
4
TDC
28
2
JCI
42
4
O
39
2
ORCL
52
5
MSFT
48
2
JPM
55
2
CI
63
-5
AES
44
-3
MLM
48
3
ALL
54
-4
APD
37
-3
PHM
43
-5
URBN
52
-3
Financhill
Back

SpringWorks Therapeutics 10K Form

Sell
43

SWTX
SpringWorks Therapeutics

Last Price:
$49.75
Seasonality Move:
-16.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SWTX News And Ratings

See the #1 stock for the next 7 days that we like better than SWTX

SWTX Financial Statistics

Sales & Book Value

Annual Sales: $191.6M
Cash Flow: $-35.6M
Price / Cash Flow: 0
Annual Sales: $6.47
Price / Book: 7.93

Profitability

EPS (TTM): -3.48000
Net Income (TTM): $-258.1M
Gross Margin: $179M
Return on Equity: -46.69%
Return on Assets: -40.38%

SpringWorks Therapeutics Earnings Forecast

Key SpringWorks Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 4 years for SWTX is 93.45%.
  • The Selling, General & Administrative Expenses for SWTX have been equal to 133.96% of Gross Profit Margin.
  • The Research & Development expenses have been 104.66% of Revenue.
  • The Net Earning history of SWTX is -134.73% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

SpringWorks Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SWTX
CUSIP: 85205L
Website: springworkstx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.81
Quick Ratio: 3.54

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 449.89

SWTX Technical Analysis vs Fundamental Analysis

Sell
43
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy or a Sell?